VIDEO: Sustained delivery of gene therapy in development

Both subretinal and intravitreal vectors for delivering gene therapy are in development for treatment of neovascular age-related macular degeneration. These sustained delivery methods have potential to offer patients long-term therapy with a single intervention according to SriniVas Sadda, MD, who spoke on the topic at the Retina 2016 meeting.